Sign Out
In dysfunctional uterine bleeding, cystic glandular hyperplasia of the endometrium (provided the functional nature of the bleeding was confirmed by a histological test within 6 months): daily 5-10 mg (1-2 tablets) for 6-12 days. To prevent any relapse daily 5-10 mg (1-2 tablets) from the 16th to the 25th day of the cycle, in general combined with oestrogen.
Endometriosis, adenomyosis: daily 5 mg (1 tablet) from the 5th to the 25th day of the cycle for 6 months, or if taken continuously, it should be begun with 2.5 mg (half a tablet) daily on the 5th day of the cycle and to prevent inter-menstrual bleeding the dose should be increased by half a tablet every 2-3 weeks for as long as 4-6 months.
Postponement of menstruation: In cases of too frequent menstrual bleeding, and in special circumstances (e.g. operations, travel, sports) the postponement of menstruation is possible. Take 1 tablet of Norcolut three times daily for no longer than 10 to 14 days, starting 3 days before the expected onset of menstruation. A normal period should occur 2-3 days after the patient has stopped taking tablets. (See Tables 1 and 2.)
Click on icon to see table/diagram/image
Click on icon to see table/diagram/imageIn dysfunctional bleeding during the menopause: a daily dose of 5 mg (1 tablet) is recommended for 10-20 days in the second half of the cycle. It should be completed with oestradiol therapy.
Special populations: Patients with renal impairment: No studies have been performed in patients with renal insufficiency.
Patients with hepatic impairment: No studies have been performed in patients with hepatic insufficiency.
Elderly: No studies have been performed in elderly patients (>65 years).
Paediatric population: Limited amount of data are available, therefore the use of Norcolut is not indicated in children.
Route of Administration: Oral use.
The tablets are to be swallowed with some liquid.
Continue with Google